|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Investment in hotel properties, net (Note 3) | ||||||||||||||||||||
| Note receivable (Note 3) | ||||||||||||||||||||
| Note receivable held for sale (Note 13) | ||||||||||||||||||||
| Property under development | ||||||||||||||||||||
| Assets held for sale (Note 3) | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash reserves (Note 5) | ||||||||||||||||||||
| Hotel receivables (net of allowance for doubtful accounts of $395 and $404, respectively) | ||||||||||||||||||||
| Debt issuance costs for borrowings under credit facilities, net | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Borrowings under credit facilities (Note 4) | ||||||||||||||||||||
| Term loans, net of unamortized debt issuance costs (Note 4) | ||||||||||||||||||||
| Bonds payable, net of unamortized debt issuance costs (Note 4) | ||||||||||||||||||||
| Mortgage loan, net of unamortized debt issuance costs (Note 4) | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Liabilities of assets held for sale (Note 3) | ||||||||||||||||||||
| Advance deposits | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Distributions payable | ||||||||||||||||||||
| Deferred deposit on Merger transaction (Note 1) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Shareholders’ Equity: | ||||||||||||||||||||
| Preferred shares of beneficial interest, $0.01 par value (liquidation preference of $260,000), 40,000,000 shares authorized; 10,400,000 shares issued and outstanding (Note 6) | ||||||||||||||||||||
| Common shares of beneficial interest, $0.01 par value, 200,000,000 shares authorized; 113,251,427 shares issued and 110,397,737 shares outstanding, and 113,251,427 shares issued and 113,209,392 shares outstanding, respectively (Note 6) | ||||||||||||||||||||
| Treasury shares, at cost (Note 6) | ||||||||||||||||||||
| Additional paid-in capital, net of offering costs of $82,865 and $82,842, respectively | ||||||||||||||||||||
| Accumulated other comprehensive income (Note 4) | ||||||||||||||||||||
| Distributions in excess of retained earnings | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Noncontrolling Interests: | ||||||||||||||||||||
| Noncontrolling interests in consolidated entities | ||||||||||||||||||||
| Noncontrolling interests of common units in Operating Partnership (Note 6) | ||||||||||||||||||||
| Total noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
